首页> 外文期刊>Artificial Organs >Extracorporeal CO 2 2 removal and regional citrate anticoagulation in an experimental model of hypercapnic acidosis
【24h】

Extracorporeal CO 2 2 removal and regional citrate anticoagulation in an experimental model of hypercapnic acidosis

机译:体外二氧化碳2 2在高碳酸中毒实验模型中去除和区域柠檬酸盐抗凝

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Abstract Low flow extracorporeal veno‐venous CO 2 removal (ECCO 2 R) therapy is used to remove CO 2 while reducing ventilation intensity. However, the use of this technique is limited because efficiency of CO 2 removal and potential beneficial effects on pulmonary hemodynamics are not precisely established. Moreover, this technique requires anticoagulation that may induce severe complications in critically ill patients. Therefore, our study aimed at determining precise efficiency of CO 2 extraction and its effects on right ventricular (RV) afterload, and comparing regional anticoagulation with citrate to systemic heparin anticoagulation during ECCO 2 R. This study was performed in an experimental model of severe hypercapnic acidosis performed in two groups of three pigs. In the first group (heparin group), pigs were anticoagulated with a standard protocol of unfractionated heparin while citrate was used for ECCO 2 R device anticoagulation in the second group (citrate group). After sedation, analgesia and endotracheal intubation, pigs were connected to a volume‐cycled ventilator. Severe hypercapnic acidosis was obtained by reducing tidal volume by 60%. ECCO 2 R was started in both groups when arterial pH was lower than 7.2. Pump Assisted Lung Protection (PALP, Maquet, Rastatt, Germany) system was used to remove CO 2 . CO 2 extraction, arterial pH, PaCO 2 as well as systemic and pulmonary hemodynamic were continuously followed. Mean arterial pH was normalized to 7.37 ± 1.4 at an extracorporeal blood flow of 400 mL/min, coming from 7.11 ± 1.3. RV end‐systolic pressure increased by over 30% during acute hypercapnic acidosis and was normalized in parallel with CO 2 removal. CO 2 extraction was not significantly increased in citrate group as compared to heparin group. Mean ionized calcium and MAP were significantly lower in the citrate group than in the heparin group during ECCO 2 R (1.03 ± 0.20 vs. 1.33 ± 0.19 and 57 ± 14 vs. 68 ± 15 mm Hg, respectively). ECCO 2 R was highly efficient to normalize pH and PaCO 2 and to reduce RV afterload resulting from hypercapnic acidosis. Regional anticoagulation with citrate solution was as effective as standard heparin anticoagulation but did not improve CO 2 removal and lead to more hypocalcemia and hypotension.
机译:摘要使用低流量体外静脉静脉CO 2去除(ECCO 2 R)疗法用于除去CO 2,同时降低通风强度。然而,这种技术的使用是有限的,因为不确定CO 2去除和对肺血流动力学的潜在有益效果的效率。此外,该技术需要抗凝,其可能会诱导严重病人的严重并发症。因此,我们的研究旨在确定CO 2提取的精确效率及其对右心室(RV)的效果的效果,并将柠檬酸盐与柠檬酸盐的区域抗凝血进行比较,在ECCO 2 R期间对全身肝素抗凝凝聚。该研究是在严重高碳化的实验模型中进行的酸中毒在两组三只猪中进行。在第一组(肝素基团)中,用一个未分叉的肝素的标准方案突出猪,而柠檬酸盐用于第二组(柠檬酸盐组)中的ECCO 2 R器材抗凝。镇静后,镇痛和气管插管后,猪连接到体积循环的呼吸机。通过将潮气量降低60%来获得严重的高碳酸酸中毒。当动脉pH低于7.2时,ECCO 2R在两组中开始。泵辅助肺保护(Palp,Maquet,Rastatt,德国)系统用于删除CO 2。连续遵循CO 2提取,动脉pH,PACO 2以及全身和肺血流动力学。平均动脉pH在400ml / min的体外血流下标准化为7.37±1.4,来自7.11±1.3。在急性高碳酸中毒中,RV末端收缩压增加超过30%,并与CO 2一起归一化。与肝素基团相比,CO 2萃取在柠檬酸盐组中没有显着增加。柠檬酸盐组的平均电离钙和图谱显着低于ECCO 2R期间肝素基团(1.03±0.20与1.33±0.19和57±14与68±15mm Hg)。 ECCO 2 R高效地归一化pH和PACO 2,并降低了高碳酸中毒导致的RV后载。含柠檬酸盐溶液的区域抗凝与标准肝素抗凝一样有效,但没有改善CO 2去除并导致更多的低钙血症和低血压。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号